Journal Editorial - Translating HARMS2-AF into benefits for our atrial fibrillation patients and the general public: challenges and opportunities
ESC Cardio Talk
00:00
Discussing the Limitations of the Study
Discussion of the limitations and strengths of the study being analyzed, including the reliance on self-report for lifestyle factors and the issue with outcome ascertainment in the UK biobank.
Play episode from 12:14
Transcript
